Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa
- PMID: 17721937
- DOI: 10.1002/jps.21077
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa
Abstract
The vaginal mucosa is commonly exposed to a variety of topical agents, including chemical contraceptives, drugs for the treatment of specific pathological conditions, and pathogenic microorganisms. In vitro models can provide important information regarding the penetration and efficacy of topical compounds as well as the pathogenesis of various diseases such a menstrual toxic shock syndrome. Realistic and reproducible test systems are important if new agents are to fulfill their therapeutic potential in human populations. The selection of appropriate animal species and tissue and the use of valid in vitro systems can avoid many of the shortcomings of current animal and cell culture test systems. This review provides information about the factors that should be considered when selecting the best model to study the permeability of the human vagina. The characteristics of an ex vivo porcine model are explored and the validity of this model is demonstrated in terms of its histology, ultrastructure and composition and organization of the permeability barrier; data indicate excellent correlation of permeability and tissue response between human and porcine vaginal tissue.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Use of porcine vaginal tissue ex-vivo to model environmental effects on vaginal mucosa to toxic shock syndrome toxin-1.Toxicol Appl Pharmacol. 2014 Jan 15;274(2):240-8. doi: 10.1016/j.taap.2013.11.021. Epub 2013 Dec 10. Toxicol Appl Pharmacol. 2014. PMID: 24333258
-
Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage.Am J Obstet Gynecol. 2003 Dec;189(6):1785-91. doi: 10.1016/s0002-9378(03)00873-1. Am J Obstet Gynecol. 2003. PMID: 14710116
-
Use of an Ex Vivo Porcine Mucosal Model to Study Superantigen Penetration.Methods Mol Biol. 2016;1396:133-147. doi: 10.1007/978-1-4939-3344-0_12. Methods Mol Biol. 2016. PMID: 26676044
-
A morphologist's approach to the vagina.Acta Obstet Gynecol Scand Suppl. 1996;163:3-10. Acta Obstet Gynecol Scand Suppl. 1996. PMID: 8916469 Review.
-
Studies and methodologies on vaginal drug permeation.Adv Drug Deliv Rev. 2015 Sep 15;92:14-26. doi: 10.1016/j.addr.2015.02.003. Epub 2015 Feb 16. Adv Drug Deliv Rev. 2015. PMID: 25689736 Review.
Cited by
-
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.PLoS One. 2025 Apr 9;20(4):e0316334. doi: 10.1371/journal.pone.0316334. eCollection 2025. PLoS One. 2025. PMID: 40203246 Free PMC article. Clinical Trial.
-
Novel toxic shock syndrome toxin-1 amino acids required for biological activity.Biochemistry. 2008 Dec 9;47(49):12995-3003. doi: 10.1021/bi801468w. Biochemistry. 2008. PMID: 19012411 Free PMC article.
-
Staphylococcal and streptococcal superantigen exotoxins.Clin Microbiol Rev. 2013 Jul;26(3):422-47. doi: 10.1128/CMR.00104-12. Clin Microbiol Rev. 2013. PMID: 23824366 Free PMC article. Review.
-
Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation.Front Cell Infect Microbiol. 2012 May 9;2:64. doi: 10.3389/fcimb.2012.00064. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22919655 Free PMC article.
-
Genitourinary Tissue Engineering: Reconstruction and Research Models.Bioengineering (Basel). 2021 Jul 13;8(7):99. doi: 10.3390/bioengineering8070099. Bioengineering (Basel). 2021. PMID: 34356206 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical